Ultimately, biomarker-guided precision medicine, leveraging baseline amylin levels, eating-behavior phenotypes or genetic polymorphisms in amylin-receptor signaling, may identify the sub-populations most likely to derive incremental benefit, thereby maximizing the therapeutic and economic value of GLP-1/amylin co-therapy
Wettergren Y, Odin E, Carlsson G, Gustavsson B
Always use certified laboratory-grade bacteriostatic water or sterile saline to prevent bacterial proliferation inside the vial matrix
Microbiota and maintenance of skin barrier function
Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort study
Moreover, I review the role of body movement in the workspace